Activation Capital is seeking an anchor tenant for its planned 102,000-square-foot, $53 million innovation center and is looking to Under Armour’s corporate campus in Baltimore and Capital One’s 1717 Michael Wassmer Innovation Center in Richmond for inspiration. The building, to be located in Activation Capital’s VA Bio+Tech Park in Richmond, has been planned for 20 …

With funding from Virginia Catalyst, also known as the Virginia Biosciences Health Research Corp., Virginia Tech is engaged in three collaborative bioscience projects to address unmet health care needs in Virginia, according to Michael Friedlander, vice president for health sciences and technology at Virginia Tech. The Catalyst awards, which range from $350,000 to $800,000, support joint research projects between industry and Virginia universities …

ReAlta Life Sciences (“ReAlta”), Inc., a clinical mid-stage biotech company dedicated to addressing life-threatening rare diseases by harnessing the power of the immune system,  announced dosing of the first patient in a Phase 2 clinical trial evaluating the safety and efficacy of RLS-0071 for the treatment of hypoxic ischemic encephalopathy (HIE) in newborns. RLS-0071, an …

RIVANNA®, developers of imaging-based medical solutions, announced that they have received funding totaling $30.5 million over 39 months from early execution of an option by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The funding …

Virginia Bio and its member companies Ampel BioSolution, Canon Virginia Inc., City of Virginia Beach, CytoRicovery, LifeNet Health, Marsh McLennan Agency, PAK Biosolutions, and ReAlta Life Sciences, are recognized as the 2023 Top Virginia Employers for Interns! Read more about this award that recognizes companies and organizations that foster talent development in Virginia in the article below.   …

Tympanogen, a medical device company based in the Biotech Park of Richmond, VA, was awarded a $3.23 million Small Business Innovation Research (SBIR) grant from the National Institute on Deafness and Other Communication Disorders (NIDCD). This Commercialization Readiness Pilot (CRP) Program grant, a continuation of a prior Direct-to-Phase II grant, will support the pivotal clinical …